FORA Capital’s Ascendis Pharma A/S ASND Stock Holding History

FORA Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,649	Closed	-$703K	–	362
2024 Q1	$703K	Buy	+4,649	New	+$664K	0.06%	278
2022 Q2	–	Sell	-10,000	Closed	-$1.16M	–	427
2022 Q1	$1.16M	Buy	+10,000	New	+$1.16M	0.21%	138
2021 Q2	–	Sell	-1,015	Closed	-$131K	–	872
2021 Q1	$131K	Buy	+1,015	New	+$154K	0.04%	360
2020 Q3	–	Sell	-501	Closed	-$74K	–	654
2020 Q2	$74K	Buy	+501	New	+$68.8K	0.03%	566

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FORA Capital's ASND Position: Q2 2024 in Review

FORA Capital sold out of Ascendis Pharma A/S (ASND) in Q2 2024, closing a stake of 4,649 shares — an estimated $703K sold.

FORA Capital first reported a position in ASND in Q2 2020 and held it in 4 quarters. The position peaked at $1.16M in Q1 2022. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.

FORA Capital reported no remaining Ascendis Pharma A/S position as of Q2 2024 after selling out during the quarter.
FORA Capital sold 4,649 Ascendis Pharma A/S shares in Q2 2024, an estimated $703K.
FORA Capital first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 4 quarters.
FORA Capital's Ascendis Pharma A/S position peaked at $1.16M in Q1 2022.
203 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2024.

Based on FORA Capital's 13F filing for Q2 2024, filed 13 Aug 2024.